Developer docs
API playgroundTry for free, no card

Search company profiles

W Fund

Full company profile

uuid0007w8o

Namestring
W Fund
Legal namestring
W Fund
Websiteurl
thewfund.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

W Fund is a Seattle-based, early-stage venture capital fund established in 2012 to provide seed and pre-seed capital to technology-based startup companies spinning out of the University of Washington and other Washington state research institutions. The fund operates with a five-member Board of Directors led by General Manager Linden Rhoads, former UW Vice Provost for Commercialization, and a 20-member Investment Committee that includes senior investment professionals from Madrona Venture Group, ARCH Venture Partners, WRF Capital, OVP, Point B Capital, and Alexandria Venture Investments. Its mandate explicitly covers spin-outs from Washington State University, Fred Hutchinson Cancer Research Center, Benaroya Research Institute, Seattle Children's Research Institute, Seattle Biomed, and Pacific Northwest National Laboratory, alongside the University of Washington's Center for Commercialization (C4C).

The fund's investment product is capital and ecosystem support: initial investments of up to $500K when participating in rounds of $1 million or more, with the option to lead alone and to make follow-on investments in portfolio companies. Entrepreneurs apply through the fund's website, selected companies present to a Screening Committee, and those that pass undergo due diligence and formal Investment Committee review. W Fund also operates the Student Venture Associates Program in collaboration with UW C4C and the Foster School's Center for Innovation and Entrepreneurship to give UW students experiential involvement in the diligence process. Portfolio companies span Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Tech/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS).

W Fund generates revenue through the standard venture capital model of management fees on committed capital and carried interest on successful portfolio exits. The fund was anchored by the Washington Research Foundation and UW Center for Commercialization with a stated target of investing approximately $20 million over four years. Its website currently indicates W Fund is no longer accepting new applications for investment consideration, consistent with the conclusion of its original investment period and a transition into portfolio harvest.

Short descriptiontext

W Fund is a Seattle-based, early-stage venture capital fund founded in 2012 that invests seed capital of up to $500K in technology startups spinning out of the University of Washington and other Washington state research institutions, partnering with the Washington Research Foundation and a 20-member regional Investment Committee.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
early-stage venture capital, seed stage investing, technology startup funding, university spin-out investing, Pacific Northwest venture capital
Industry1 code
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
NAICS code1 code
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns (Management Fees and Carried Interest)
TypeManaged Services
Description

As an early-stage venture fund, W Fund generates returns through management fees on committed capital and carried interest on successful portfolio exits. The fund aims to invest approximately $20 million over four years across multiple portfolio companies, seeking to help startups reach venture-fundable milestones.

thewfund.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

W Fund is an early-stage venture capital fund that makes seed and early-stage investments of up to $500K in technology-based startups spinning out of the University of Washington and other research institutions across Washington state. The fund targets participation in rounds of $1M or more, aims to invest approximately $20 million over four years, and seeks to bridge the gap between research and venture-fundable milestones through follow-on capital.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

W Fund is a venture capital firm, not a product company. The W Fund makes earliest-stage investments to accelerate the success of Washington's most promising technology-based start-up companies originating from research institutions and students across the state. The Fund targets initial investments of up to $500K and seeks to partner with other venture and angel groups on larger investments. Its portfolio companies span multiple sectors including Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Technology/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS). W Fund also operates the Student Venture Associates Program in collaboration with UW to provide experiential learning opportunities for students.

Product and service1 record
1Seed and Early-Stage Venture Capital Investment
CategoryVenture Capital / Seed Investing
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1University of Washington (Center for Commercialization / C4C)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund is the primary investment vehicle for spin-outs from the University of Washington's Center for Commercialization. The fund works closely with C4C to identify and evaluate promising research-based startups for investment.

thewfund.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Washington State University as part of its mandate to support research institution spin-outs across Washington state.

3Foster School's Center for Innovation and Entrepreneurship
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Student Venture Associates program was established by UW Center for Commercialization (C4C), funded by both C4C and Washington Research Foundation, working in collaboration with the Foster School's Center for Innovation and Entrepreneurship to provide experiential learning opportunities for UW students.

thewfund.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Fred Hutchinson Cancer Research Center as part of its mandate to support Washington state research institution spin-outs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Benaroya Research Institute as part of its mandate to support Washington state research institution spin-outs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Seattle Children's Research Institute as part of its mandate to support Washington state research institution spin-outs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Seattle Biomed as part of its mandate to support Washington state research institution spin-outs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

W Fund invests in companies spinning out from Pacific Northwest National Laboratory as part of its mandate to support Washington state research institution spin-outs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

WRF Capital is the venture investment arm of the Washington Research Foundation and a co-investor/partner of W Fund. It invests in Washington state university spin-outs across life sciences and physical sciences, making it the most directly comparable peer.

TypeBroad incumbent
Description

Pacific Northwest-focused early-to-growth-stage VC. While not exclusively university-focused, Madrona has institutional ties to UW and serves on W Fund's Investment Committee, representing the broader regional VC bench against which W Fund competes for deals.

TypeBroad incumbent
Description

ARCH is a large, established venture firm with deep biotech expertise; Steve Gillis (ARCH Managing Director) sits on W Fund's Investment Committee. ARCH represents the broader VC ecosystem that often co-invests in, or takes over, W Fund's university spin-outs.

TypeDirect peer
Description

Alexandria's venture arm invests in early-stage life sciences companies, frequently participating in university spin-outs. Monica Beam (Alexandria) sits on W Fund's Investment Committee, indicating overlap in deal flow and investment focus area.

TypeDirect peer
Description

A Seattle-based pre-seed/seed venture fund focused on Pacific Northwest founders. Founders' Co-op invests at a similar earliest-stage and competes with W Fund for Washington state talent and spin-outs.

TypeDirect peer
Description

Pioneer Fund is a US early-stage venture fund investing in diverse founding teams, with a comparable pre-seed/seed check size and analogous limited-partner-driven fund structure typical of emerging VC firms.

7OVP (Obvious Ventures)
TypeBroad incumbent
Description

Impact-oriented VC investing across IT, clean tech, and digital biology sectors. Chad Waite (OVP Managing Director) sits on W Fund's Investment Committee, representing an overlapping investment lens on tech-enabled, mission-driven companies.

8Element 8 Angels
TypeRegional player
Description

Pacific Northwest cleantech-focused angel network. Jeff Canin (Element 8) sits on W Fund's Board, indicating co-investment partnership and overlap in clean-technology early-stage deals from Washington state research institutions.

TypeEmerging player
Description

Alternative early-stage VC primarily backing young founders and alternative-path entrepreneurs. Operates at a similar earliest-stage seed check range to W Fund and competes for the same talent-driven university-adjacent pipeline.

10Point B Capital
TypeBroad incumbent
Description

Pacific Northwest-focused venture capital firm with software/IT emphasis. John Bjornson (Point B Capital President) sits on W Fund's Investment Committee, reflecting an institutional co-investor relationship that often takes over software/IT portfolio companies as they scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment22 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

W Fund

Venture Capitalthewfund.com

W Fund is a Seattle-based, early-stage venture capital fund founded in 2012 that invests seed capital of up to $500K in technology startups spinning out of the University of Washington and other Washington state research institutions, partnering with the Washington Research Foundation and a 20-member regional Investment Committee.

What W Fund does

W Fund is a Seattle-based, early-stage venture capital fund established in 2012 to provide seed and pre-seed capital to technology-based startup companies spinning out of the University of Washington and other Washington state research institutions. The fund operates with a five-member Board of Directors led by General Manager Linden Rhoads, former UW Vice Provost for Commercialization, and a 20-member Investment Committee that includes senior investment professionals from Madrona Venture Group, ARCH Venture Partners, WRF Capital, OVP, Point B Capital, and Alexandria Venture Investments. Its mandate explicitly covers spin-outs from Washington State University, Fred Hutchinson Cancer Research Center, Benaroya Research Institute, Seattle Children's Research Institute, Seattle Biomed, and Pacific Northwest National Laboratory, alongside the University of Washington's Center for Commercialization (C4C).

The fund's investment product is capital and ecosystem support: initial investments of up to $500K when participating in rounds of $1 million or more, with the option to lead alone and to make follow-on investments in portfolio companies. Entrepreneurs apply through the fund's website, selected companies present to a Screening Committee, and those that pass undergo due diligence and formal Investment Committee review. W Fund also operates the Student Venture Associates Program in collaboration with UW C4C and the Foster School's Center for Innovation and Entrepreneurship to give UW students experiential involvement in the diligence process. Portfolio companies span Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Tech/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS).

W Fund generates revenue through the standard venture capital model of management fees on committed capital and carried interest on successful portfolio exits. The fund was anchored by the Washington Research Foundation and UW Center for Commercialization with a stated target of investing approximately $20 million over four years. Its website currently indicates W Fund is no longer accepting new applications for investment consideration, consistent with the conclusion of its original investment period and a transition into portfolio harvest.

W Fund firmographics

Firmographics
Name
W Fund
Legal name
W Fund
Website
https://thewfund.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
W Fund is a Seattle-based, early-stage venture capital fund founded in 2012 that invests seed capital of up to $500K in technology startups spinning out of the University of Washington and other Washington state research institutions, partnering with the Washington Research Foundation and a 20-member regional Investment Committee.
Ownership category
akta.pro rank

W Fund industry classification

Industry
Product category
Venture Capital
NAICS
Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)

Keywords

  • Early-stage venture capital
  • Seed stage investing
  • Technology startup funding
  • University spin-out investing
  • Pacific Northwest venture capital

Where W Fund is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices1 record

Markets served

W Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Venture Capital Returns (Management Fees and Carried Interest): As an early-stage venture fund, W Fund generates returns through management fees on committed capital and carried interest on successful portfolio exits. The fund aims to invest approximately $20 million over four years across multiple portfolio companies, seeking to help startups reach venture-fundable milestones.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

W Fund product offering

Product offering

Core offering

W Fund is an early-stage venture capital fund that makes seed and early-stage investments of up to $500K in technology-based startups spinning out of the University of Washington and other research institutions across Washington state. The fund targets participation in rounds of $1M or more, aims to invest approximately $20 million over four years, and seeks to bridge the gap between research and venture-fundable milestones through follow-on capital.

Product overview

W Fund is a venture capital firm, not a product company. The W Fund makes earliest-stage investments to accelerate the success of Washington's most promising technology-based start-up companies originating from research institutions and students across the state. The Fund targets initial investments of up to $500K and seeks to partner with other venture and angel groups on larger investments. Its portfolio companies span multiple sectors including Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Technology/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS). W Fund also operates the Student Venture Associates Program in collaboration with UW to provide experiential learning opportunities for students.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seed and Early-Stage Venture Capital Investment

Companies that use W Fund

Customer profile

Segments1 record

Ideal customer profiles1 record

W Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

W Fund partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • University of Washington (Center for Commercialization / C4C)coreStrategic or Co-development PartnerW Fund is the primary investment vehicle for spin-outs from the University of Washington's Center for Commercialization. The fund works closely with C4C to identify and evaluate promising research-based startups for investment.
  • Washington State UniversitycoreStrategic or Co-development PartnerW Fund invests in companies spinning out from Washington State University as part of its mandate to support research institution spin-outs across Washington state.
  • Foster School's Center for Innovation and EntrepreneurshipcoreStrategic or Co-development PartnerThe Student Venture Associates program was established by UW Center for Commercialization (C4C), funded by both C4C and Washington Research Foundation, working in collaboration with the Foster School's Center for Innovation and Entrepreneurship to provide experiential learning opportunities for UW students.
  • Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerW Fund invests in companies spinning out from Fred Hutchinson Cancer Research Center as part of its mandate to support Washington state research institution spin-outs.
  • Benaroya Research InstitutecoreStrategic or Co-development PartnerW Fund invests in companies spinning out from Benaroya Research Institute as part of its mandate to support Washington state research institution spin-outs.
  • Seattle Children's Research InstitutecoreStrategic or Co-development PartnerW Fund invests in companies spinning out from Seattle Children's Research Institute as part of its mandate to support Washington state research institution spin-outs.
  • Seattle BiomedcoreStrategic or Co-development PartnerW Fund invests in companies spinning out from Seattle Biomed as part of its mandate to support Washington state research institution spin-outs.
  • Pacific Northwest National Laboratory (PNNL)coreStrategic or Co-development PartnerW Fund invests in companies spinning out from Pacific Northwest National Laboratory as part of its mandate to support Washington state research institution spin-outs.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

W Fund competitors and assessment

Company assessment

Direct peers

  • WRF Capital: WRF Capital is the venture investment arm of the Washington Research Foundation and a co-investor/partner of W Fund. It invests in Washington state university spin-outs across life sciences and physical sciences, making it the most directly comparable peer.
  • Alexandria Venture Investments: Alexandria's venture arm invests in early-stage life sciences companies, frequently participating in university spin-outs. Monica Beam (Alexandria) sits on W Fund's Investment Committee, indicating overlap in deal flow and investment focus area.
  • Founders' Co-op: A Seattle-based pre-seed/seed venture fund focused on Pacific Northwest founders. Founders' Co-op invests at a similar earliest-stage and competes with W Fund for Washington state talent and spin-outs.
  • Pioneer Fund: Pioneer Fund is a US early-stage venture fund investing in diverse founding teams, with a comparable pre-seed/seed check size and analogous limited-partner-driven fund structure typical of emerging VC firms.

Broad incumbents

  • Madrona Venture Group: Pacific Northwest-focused early-to-growth-stage VC. While not exclusively university-focused, Madrona has institutional ties to UW and serves on W Fund's Investment Committee, representing the broader regional VC bench against which W Fund competes for deals.
  • ARCH Venture Partners: ARCH is a large, established venture firm with deep biotech expertise; Steve Gillis (ARCH Managing Director) sits on W Fund's Investment Committee. ARCH represents the broader VC ecosystem that often co-invests in, or takes over, W Fund's university spin-outs.
  • OVP (Obvious Ventures): Impact-oriented VC investing across IT, clean tech, and digital biology sectors. Chad Waite (OVP Managing Director) sits on W Fund's Investment Committee, representing an overlapping investment lens on tech-enabled, mission-driven companies.
  • Point B Capital: Pacific Northwest-focused venture capital firm with software/IT emphasis. John Bjornson (Point B Capital President) sits on W Fund's Investment Committee, reflecting an institutional co-investor relationship that often takes over software/IT portfolio companies as they scale.

Regional players

  • Element 8 Angels: Pacific Northwest cleantech-focused angel network. Jeff Canin (Element 8) sits on W Fund's Board, indicating co-investment partnership and overlap in clean-technology early-stage deals from Washington state research institutions.

Emerging players

  • 1517 Fund: Alternative early-stage VC primarily backing young founders and alternative-path entrepreneurs. Operates at a similar earliest-stage seed check range to W Fund and competes for the same talent-driven university-adjacent pipeline.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

W Fund social profiles

Digital presence

W Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

W Fund leadership team

Management profile

Number of profiles

Profiles5 records

W Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

W Fund M&A and investment

M&A and investment

M&A

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about W Fund

What does W Fund do?

W Fund is an early-stage venture capital fund that makes seed and early-stage investments of up to $500K in technology-based startups spinning out of the University of Washington and other research institutions across Washington state. The fund targets participation in rounds of $1M or more, aims to invest approximately $20 million over four years, and seeks to bridge the gap between research and venture-fundable milestones through follow-on capital.

Is W Fund a public or private company?

W Fund is a private company. It is classified as unknown and is currently operating.

When was W Fund founded?

W Fund was founded in 2012. It employs 1 to 10 people.

Where is W Fund based?

W Fund is headquartered in Seattle, United States, in the North America region.

How does W Fund make money?

One revenue line is on record: venture Capital Returns (Management Fees and Carried Interest).

Who are W Fund's main competitors?

Direct peers on record are WRF Capital, Alexandria Venture Investments, Founders' Co-op and Pioneer Fund. Broad incumbents are Madrona Venture Group, ARCH Venture Partners, OVP (Obvious Ventures) and Point B Capital. Element 8 Angels is listed as a regional player. 1517 Fund is listed as an emerging player.

Does W Fund have an API?

No public API is recorded for W Fund.

What industry is W Fund in?

W Fund's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesFog Corporation, which operates the online lottery platform "RAFFLE," has raised approximately 300 million yen in Series A funding and has transferred part of the common stock held by United Corporation.Fogg Inc., the operator of online lottery platform RAFFLE, has raised approximately 300 million yen in Series A funding led by NTT Docomo Ventures and W fund. The company also transferred part of its common stock held by existing shareholder United Inc. to external investors for the first time since its founding.LinkedInW fund invested in Dagangan! 🚚✨🌴 Dagangan, our latest investment, is a tech-enabled rural commerce platform in Indonesia that provides affordable daily necessities to rural communities, aiming to…W fund has invested in Dagangan, a tech-enabled rural commerce platform in Indonesia that connects producers and micro-entrepreneurs with rural communities. The company, which has raised $18.5 million, aims to expand its network from 25,000 to 75,000 villages across Java to address the untapped potential of the Indonesian rural market.LinkedInW fund invested in Jendela360! 🏠✨ Jendela, our latest investment, is a unique end-to-end property platform that revolutionizes the property buying and renting processes in Indonesia. Unlike other…W fund has invested in Jendela360, a property platform that aims to revolutionize the property buying and renting processes in Indonesia. The investment is aimed at expanding Jendela's services to other major cities, tapping into the estimated $80 billion prop-tech market. Jendela aspires to become a dominant player in the industry with the backing of W fund.PrtimesThe first overseas expansion as a domestic fresh pet food. Biophilia, which provides Coco Gourmet, has conducted a Series B first close fundraising, with a total fundraising amount of approximately 1.2 billion yen.Biophilia Co., Ltd. has raised approximately 1.2 billion yen through a Series B funding round led by W fund, with participation from existing and new investors including Adlib Tech Ventures and KxShare. The company plans to utilize the capital for its first-ever overseas expansion as a domestic fresh pet food brand, alongside strengthening its supply chain and product development.MatildaThe home-cooked meal takeout station 'Matilda' has raised 350 million yen in funding to expand its offerings.Matilda Co., Ltd. has raised approximately 350 million yen in a Series A funding round to expand its home-cooked meal takeout service. The company plans to use the capital to establish a new central kitchen in Koto-ku, Tokyo, by November 2023, aiming to meet growing demand from dual-income families. This expansion is supported by investors including W fund, ANRI, and Lotte Ventures Japan.PrtimesPaytoner has raised approximately 1.9 billion yen in funding to develop a cash management platform focused on small businesses.Paytner Co., Ltd. has raised approximately 1.9 billion yen through a Series B funding round led by W fund, involving debt financing from eight companies including Orix Capital and FFG Venture Business Partners. This transaction brings the total capital raised by the Tokyo-based firm since its founding in 2019 to over 2.5 billion yen.FinSMEsCyrus Biotechnology Raises $8M in FundingCyrus Biotechnology closed an $8M Series A financing led by Trinity Ventures, with participation from OrbiMed Advisors, SpringRock Ventures, W Fund, and individual investors. Gus Tai and Eric Bell will join the board. The Seattle-based company provides computational protein modeling software for drug discovery.GeekWireUW spin out Qazzow scores $500,000, helps customers get questions answered on e-commerce sitesQazzow, a UW spinout, raised $500,000 in seed funding from the W Fund, the first financed startup from the UW's Information School. The company's Q&A SaaS aims to boost e-commerce sales conversions and cut support costs by up to 50%, with customers 12 times more likely to purchase.VC News DailyBEATBio Closes $2.5M Seed RoundBEATBio, a Seattle-based biotechnology company, announced the closing of a $2.5 million seed stage investment to advance its novel gene therapy for heart failure into clinical development. The funding round was led by CET Capital Partners, with participation from the W Fund, and will support moving the company's lead product forward. The therapy is based on research from the University of Washington demonstrating that a small increase in a naturally occurring enzyme can improve cardiac muscle pumping power.